Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05180045 · ClinicalTrials.gov registry record · NA
Home Blood Pressure Telemonitoring LINKED With Community Health Workers to Improve Blood Pressure
A NA study of Hypertension and High Blood Pressure, sponsored by Johns Hopkins University.
- Active
- Registry status
- NA
- Development phase
- 472
- Enrollment target
- 20
- Study locations
NCT05180045: Active NA study of Hypertension and High Blood Pressure, sponsored by Johns Hopkins University.
NCT05180045 is a NA study of Hypertension and High Blood Pressure that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 472 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (87% lower). The trial reports 20 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05180045, a NA study of Hypertension and High Blood Pressure, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 472 participants
- Enrollment target
- 20
- Study locations
Study Summary
The LINKED-BP Program is a patient-centered, multi-level intervention linking home blood pressure monitoring (HBPM) with a telemonitoring platform (Sphygmo) that links with all Bluetooth-enabled validated blood pressure (BP) devices, support from community health workers (CHWs), and BP measurement training at community health centers serving high-risk adults to prevent stage 2 hypertension (BP ≥ 140/90 mm Hg). The LINKED-BP Program study will recruit a total of 600 adults (30 from each practice) with elevated BP (120-129/\<80 mm Hg) or untreated stage 1 hypertension (130-139/80-89 mm Hg) across 20 community health centers or primary care practices serving high-risk adults. This cluster-randomized trial consists of two arms: (1) enhanced "usual care arm," wherein patients will be provided with Omron 10 series home BP monitors (HBPM) and will be managed by the patients' primary care clinicians as usual; and (2) the LINKED-BP Program or "intervention arm," which will include training of patients on HBPM, Sphygmo BP telemonitoring app, and CHW visits for education and counseling on lifestyle modification. The intervention period for each study participant is 12 months.
Primary Outcome
Change in systolic blood pressure in millimeters of mercury (mmHg) over a 12 month period.
Conditions Studied
Interventions
- BEHAVIORAL LINKED-BP Program
Study Locations (20)
Maryland
- Johns Hopkins Community Physicians Remington - Baltimore
- Johns Hopkins Community Physicians Bowie - Bowie
- Johns Hopkins Community Physicians Brandywine - Brandywine
- Choptank Fassett Magee Medical and Cambridge Dental Center - Cambridge
- Choptank Denton Health Center - Denton
- Johns Hopkins Community Physicians Greater Dundalk - Dundalk
- Choptank Easton Health Center - Easton
- Choptank Federalsburg Medical and Dental Center - Federalsburg
- Johns Hopkins Community Physicians Fulton - Fulton
- Choptank Goldsboro - Goldsboro
- Johns Hopkins Community Physicians White Marsh - Nottingham
- Choptank Bay Hundred - Saint Michaels
- Johns Hopkins Community Physicans Charles County-White Plains - White Plains
District of Columbia
- Johns Hopkins Community Physicians I Street - Washington D.C.
- Unity Upper Cardozo Health Center - Washington D.C.
- Unity Brentwood Health Center - Washington D.C.
- Unity East of the River - Washington D.C.
- Unity Minnesota Avenue Health Center - Washington D.C.
- Unity Parkside Health Center - Washington D.C.
- Unity Anacostia Health Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 472 participants |
| Start Date | 2023-07-17 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT05180045 still lists
NCT05180045 is an interventional study that assigns participants to a tested intervention. The registered 472 participants enrollment target is mid-sized for trials with a published cap, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which LINKED-BP Program is the first listed.
NCT05180045 names 20 study sites across 2 states, led by Maryland, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05180045 about?
NCT05180045 is a clinical study titled "Home Blood Pressure Telemonitoring LINKED With Community Health Workers to Improve Blood Pressure". The LINKED-BP Program is a patient-centered, multi-level intervention linking home blood pressure monitoring (HBPM) with a telemonitoring platform (Sphygmo) that links with all Bluetooth-enabled validated blood pressure (BP) devices, support from community health workers (CHWs), and BP measurement t...
What is the current status of trial NCT05180045?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 472 participants. The study started on 2023-07-17. Estimated completion is 2026-06-30.
What conditions does trial NCT05180045 study?
This clinical trial studies the following conditions: Hypertension, High Blood Pressure.
What interventions are being tested in trial NCT05180045?
The interventions under investigation include: LINKED-BP Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05180045?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05180045 being conducted?
This trial has 20 study locations across District of Columbia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05180045's enrollment target sits among peer trials
472 131st of 470 higher than 340 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06375083 · 472 participants · Phase 2
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
- NCT06947187 · 472 participants · NA
Vaccine Confidence and Infodemic in Southeast Asia's Nusantara Sociocultural Sphere
- NCT07199517 · 472 participants · NA
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
- NCT07225881 · 472 participants · NA
Eatwell Clinical Trial (R01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI